Qingdao Sino-Cell Biomedicine Co., Ltd.

Privately held: no public share price · China

Assets

(1 total)
1Total Assets
0Approved
0Phase 3 / Filed
1Phase 1–2 / Early
3Diseases
Quick filter:
Showing 1 of 1 assets
Target & Modality
Phase 2
Autologous tumor neoantigens (polyclonal, patient-specific)Cell therapy
Non-Small Cell Lung CancerRenal Cell CarcinomaMelanoma
Clear Cell Renal Cell Carcinoma

Upcoming events

No upcoming trial completions or earnings dates on record for this company's assets.

Financial reports

No financial reports recorded.